Development Of Scalable Purification For Biotherapeutic Peptides (GLP-1s) With Neopharm Boston

This webinar offers a comprehensive overview of the principles and best practices for achieving robust reversed-phase (RP) isolation of biotherapeutic peptides, with a focus on Liraglutide—a GLP-1 receptor agonist. It begins by outlining a systematic approach to selecting the most suitable RP column and eluent, followed by detailed guidance on developing an effective separation method at the analytical scale. Gain practical insights into the successful transfer of this method to a Waters Peptide Separation Optimum Bed Technology (OBD) preparative column. These columns are rigorously QC-tested using complex peptide mixtures to ensure consistent and reliable performance.

Whether you're optimizing peptide purification workflows or scaling up for production, deepen your understanding and elevate your peptide purification capabilities.